Table of Contents
Polyomavirus Life Cycle.- Transformation by Polyomaviruses.- Polyomaviruses and Disease.- The Life Cycle of Human Papillomaviruses.- Papillomavirus Transformation.- Papillomaviruses: Biology, Diversity, and Pathogenesis.- Adenovirus Transformation.- Overview of the Large DNA Tumor Viruses.- Epidemiology of EBV Infection.- EBV Diseases.- The Epstein–Barr Virus Genome.- Epstein–Barr Virus Transforming Proteins: Biologic Properties and Contribution to Oncogenesis.- The Epstein–Barr Virus Lytic Life Cycle.- Epstein–Barr Virus Latent Infection Nuclear Proteins: Genome Maintenance and Regulation of Lymphocyte Cell Growth and Survival.- Epstein–Barr Virus Entry.- EBV Immunotherapy.- KSHV Epidemiology and Subtype Evolution.- to Diseases Associated with Kaposi’s Sarcoma-Associated Herpesvirus.- Organization and Expression of the Kaposi’s Sarcoma-Associated Herpesvirus Genome.- KSHV Latent Genes and Their Regulation.- Regulation of Expression, Mode of Action and Downstream Targets of ORF50 Protein in KSHV Lytic Cycle Activation.- HHV-8/KSHV Proteins Involved in Signaling and Transformation.- KSHV Entry and Infection of Target Cells.- KSHV Immune Evasion.- Non-coding Regulatory RNAs of the DNA Tumor Viruses.- AIDS and Associated Malignancies.- Primate Models for Gammaherpesvirus-Associated Malignancies.- Murine Gammaherpesvirus 68 Infection of Mice: A Small Animal Model for Characterizing Basic Aspects of Gammaherpesvirus Pathogenesis.
